Medications listed are available on OH EPIC Formulary, unless otherwise noted. Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
No activetuberculosis (TB),HepatitisB,orHepatitisCinfection-screening isrequiredpriortoinitiatingandduringtherapy
No known active infection
Patient is not on concurrent treatment with another IL-inhibitor, TNF-inhibitor, biologic response modifieror other non-biologic immunomodulating agent (e.g., abrocitinib, tofacitinib, baricitinib, upadacitinib, deucravacitinib, etc.)
Use withDMARDsandPDEinhibitor(apremilast)isallowable
Patient must not have had previous cell depleting therapy (anti-thymoglobulin, alemtuzumab, etc.) within past month
Psoriasis Arthritis(PsA)
Diagnosis ofPsoriasisArthritis(PsA)
For patients with predominantly axial disease, a trial and failure of ONE non-steroidal anti-inflammatory agent (NSAID), unless use is contraindicated.
OR
For patients with peripheral arthritis, a trial and failure of ONE oral disease-modifying anti rheumaticagent(DMARD)suchas methotrexate,azathioprine,sulfasalazine,orhydroxychloroquine,etc.,unlessuseis contraindicated.
Ankylosing spondylitis(AS)
Diagnosed withactiveankylosingspondylitis(AS)
Patient had an adequate trial and failure of at least TWO (2) non-steroidal anti-inflammatoryagents (NSAIDs), unless use is contraindicated
Non-radiographic Axial Spondylarthritis
Diagnosed with active axial spondylarthritis
Patient hadanadequatetrialandfailureofatleastTWO(2)non-steroidalanti-inflammatory agents (NSAIDs) unless use is contraindicated
OH Epic Formulary, available via therapy plan, restricted to:
OR